On the last day of 2023, PRIMECAP Management (Trades, Portfolio) executed a notable transaction involving shares of NetApp Inc (NASDAQ:NTAP). This trade impacted PRIMECAP Management (Trades, Portfolio)'s portfolio by a mere 0.04%, with the shares being traded at a price of $88.16 each. Following this transaction, the firm's total share count in NetApp stood at 14,709,824, making up 1.1% of its portfolio and representing a 7.14% ownership stake in the company.
PRIMECAP Management (Trades, Portfolio), a notable investment firm, has recently adjusted its investment portfolio by reducing its stake in Rhythm Pharmaceuticals Inc (NASDAQ:RYTM). This move, executed on December 31, 2023, reflects the firm's ongoing portfolio management strategy and its assessment of RYTM's investment potential.
On the last day of 2023, PRIMECAP Management (Trades, Portfolio) made a notable addition to its investment portfolio by acquiring additional shares in Biomarin Pharmaceutical Inc (NASDAQ:BMRN). This move increased PRIMECAP Management (Trades, Portfolio)'s total holdings in the company to 18,414,374 shares, solidifying its position with a 1.5% portfolio weight and a 9.78% stake in Biomarin Pharmaceutical.
PRIMECAP Management (Trades, Portfolio), a renowned investment firm, has recently increased its investment in Transocean Ltd (NYSE:RIG), a significant player in the offshore drilling sector. Currently, Transocean Ltd constitutes 0.27% of PRIMECAP Management (Trades, Portfolio)'s portfolio, with the firm holding a 6.27% stake in the traded company.
On December 31, 2023, PRIMECAP Management (Trades, Portfolio) executed a significant stock transaction involving Mattel Inc (NASDAQ:MAT), a renowned toy manufacturer. The firm decided to reduce its holdings in Mattel, signaling a shift in its investment strategy regarding the toy company. This move by PRIMECAP Management (Trades, Portfolio), a firm known for its value-driven investment approach, has caught the attention of investors and market analysts alike, prompting discussions about the implications for Mattel's stock and PRIMECAP's portfolio.